Amoxycillin (Betamox, Betamox S, Betamox Sf)
Amoxycillin
Ranbaxy Pharmaceutical (Pty) Ltd
Registration
- Applicant
- Ranbaxy Pharmaceutical (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Betamox 250 EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 250 mg AMOXYCILLIN | 250 | Y0127Y/20.1.2/127 | Registered | Not determined | None |
| Betamox 500 EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE 602,6 mg | 500 | Y0128Y/20.1.2/128 | Registered | Not determined | None |
| Betamox s EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 125 mg | Not listed | Y0129Y/20.1.2/129 | Registered | Not determined | None |
| Betamox sf* EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250 mg | Not listed | Y0130Y/20.1.2/130 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 33613.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.